These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 15892352)
1. [Non-reliable marketing of TrioBe]. Lindgren A Lakartidningen; 2005 Apr 11-17; 102(15):1160-2. PubMed ID: 15892352 [No Abstract] [Full Text] [Related]
2. [What can we learn from the marketing of TrioBe?]. Svensson S; Mellén A Lakartidningen; 2007 Feb 28-Mar 6; 104(9):690. PubMed ID: 17393869 [No Abstract] [Full Text] [Related]
4. [TrioBe--the Medical Products Agency should re-evaluate the information text in the Fass!]. Norberg B; Asplund K Lakartidningen; 2000 May; 97(20):2520, 2522. PubMed ID: 10909231 [No Abstract] [Full Text] [Related]
5. [Correct information on vitamin B12?]. Jansson JH Lakartidningen; 2000 Apr; 97(14):1732. PubMed ID: 10815401 [No Abstract] [Full Text] [Related]
6. [Preventive treatment with TrioBe--a serious alternative]. Bergman A; Lewald B Lakartidningen; 2005 May 2-15; 102(18-19):1459-60; discussion 1460. PubMed ID: 15929434 [No Abstract] [Full Text] [Related]
7. [No scientific evidence supports vitamin B treatment of patients with cardiovascular diseases]. Ekstedt B; Jansson JH; Boman K Lakartidningen; 2006 Nov 8-14; 103(45):3464-6. PubMed ID: 17140177 [No Abstract] [Full Text] [Related]
8. [Vitamins against cardiovascular diseases?]. Nexo E Ugeskr Laeger; 1994 Jun; 156(25):3785-6. PubMed ID: 8059461 [No Abstract] [Full Text] [Related]
9. [Efficacy of a combination therapy with vitamins B6, B12 and folic acid for general feeling of ill-health. Results of a non-interventional post-marketing surveillance study]. Engels A; Schröer U; Schremmer D MMW Fortschr Med; 2008 Jan; 149 Suppl 4():162-6. PubMed ID: 18402241 [TBL] [Abstract][Full Text] [Related]
10. Chloramphenicol optic neuritis. Apparent protective effects of very high daily doses of pyridoxine and cyanocobalamin. Cocke JG Am J Dis Child; 1967 Oct; 114(4):424-6. PubMed ID: 6047242 [No Abstract] [Full Text] [Related]
11. The value of diffusion-weighted imaging in the diagnosis of Marchiafava-Bignami disease: apropos of a case. Aggunlu L; Oner Y; Kocer B; Akpek S J Neuroimaging; 2008 Apr; 18(2):188-90. PubMed ID: 18318682 [TBL] [Abstract][Full Text] [Related]
12. [Public drug marketing scrutinized by IGM and NBL. Conviction in four cases]. Perman E Lakartidningen; 2005 Apr 18-24; 102(16):1262. PubMed ID: 15921101 [No Abstract] [Full Text] [Related]
13. [Marketing--alendronate versus risedronate]. Høiseth A Tidsskr Nor Laegeforen; 2005 May; 125(10):1386. PubMed ID: 15909030 [No Abstract] [Full Text] [Related]
14. [Effect of some organic and inorganic magnesium salts on lipoprotein state in rats fed with magnesium-deficient diet]. Spasov AA; Iezgitsa IN; Kharitonova MV; Kravchenko MS Eksp Klin Farmakol; 2008; 71(4):35-40. PubMed ID: 18819439 [TBL] [Abstract][Full Text] [Related]
15. Resuscitation and rescue of the pharmaceutical detail: a prescriber-drug representative collaboration. Kale SA; Barkin RL Compr Ther; 2009; 35(2):68-71. PubMed ID: 19618754 [TBL] [Abstract][Full Text] [Related]
16. [Instructions for "bomb assembly". Don't worry, it is only an antirheumatic drug]. MMW Fortschr Med; 2006 May; 148(18):17. PubMed ID: 16736679 [No Abstract] [Full Text] [Related]
17. Pharmacokinetics of metadoxine for injection after repeated doses in healthy volunteers. Lü Y; Kang ZS; Liu Y; Li TY; Xiao YH Chin Med J (Engl); 2007 Jan; 120(2):166-8. PubMed ID: 17335665 [No Abstract] [Full Text] [Related]
18. Pyridoxine in pregnant women receiving antituberculous drugs. Kittisupamongkol W BJOG; 2009 Aug; 116(9):1274; author reply 1274-5. PubMed ID: 19624445 [No Abstract] [Full Text] [Related]